The Urinary Incontinence Treatment Study (UNITS)
Primary Purpose
Urinary Incontinence, Sarcopenia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Pelvic floor muscle exercise
Sponsored by
About this trial
This is an interventional treatment trial for Urinary Incontinence
Eligibility Criteria
Inclusion Criteria:
- Women, age 70 years or older
- Diagnosis of Urinary Incontinence (defined by the QUID assessment as having subscale score for stress ≥4, and/or urge score ≥ 6)
- Willing and able to be compliant with pelvic floor muscle exercise intervention (standard of care) for 12 weeks and to log compliance
- Willing and able to undergo an extensive physical function evaluation
Exclusion Criteria:
- Prior surgical intervention for urinary incontinence within the past 12 months
- Hysterectomy within 12 months
- Diagnosis of:
- Pelvic Organ Prolapse beyond the hymenal ring
- Urogenital Fistula
- Neurogenic Overactive Bladder (associated with a diagnosis of Multiple -Sclerosis or Stroke within past 12 months)
- Incomplete Bladder Emptying/Urinary Retention with PVR >150 ml (measured by bladder scan)
- Requires assisted device (4 point cane, walker) for ambulation all /most of the time or wheelchair bound
- Having significant cognitive impairment or dementia
- Unsafe to exercise (severe cardiopulmonary disease)
- Unable/unwilling to provide informed consent
- Determined otherwise ineligible by the principal investigator
Sites / Locations
- Wake Forest Baptist Health
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Functionally impaired
Functionally normal
Arm Description
Women with urinary incontinence and short physical performance battery score of <9
Women with urinary incontinence and short physical performance battery score of > 10
Outcomes
Primary Outcome Measures
Change in number of urinary incontinence episodes
Using a voiding diary
Secondary Outcome Measures
Full Information
NCT ID
NCT03057834
First Posted
February 10, 2017
Last Updated
March 17, 2023
Sponsor
Wake Forest University Health Sciences
Collaborators
National Institute on Aging (NIA)
1. Study Identification
Unique Protocol Identification Number
NCT03057834
Brief Title
The Urinary Incontinence Treatment Study
Acronym
UNITS
Official Title
Exploring the Role of Sarcopenia and Functional Impairment on the Non-Surgical Management of Urinary Incontinence in Older Women
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
March 1, 2017 (Actual)
Primary Completion Date
January 29, 2020 (Actual)
Study Completion Date
January 29, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences
Collaborators
National Institute on Aging (NIA)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women in each group. If investigators find unequal numbers, they will adapt recruit strategies based on a woman's functional status.
Detailed Description
Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women in each group. If they find unequal numbers, they will adapt recruit strategies based on a woman's functional status.
Investigators will compare changes in outcome measures within and between groups after 6 and 12 weeks of pelvic floor muscle exercises (PFME). The change in pelvic floor strength/efficiency will be assessed by repeating the pelvic floor PERFECT assessment and will be compared between groups. Changes in UI symptoms, symptom severity, and impact of UI symptoms on quality of life will be determined using standardized measures described above. Data analysis will define associations between changes in PERFECT measures and the change in UI episodes (based on 3-day voiding diary), severity, and type (based on QUID-7), and impact on quality of life (PFIQ-7) within and between groups. Objective measurement of lower-extremity strength will inform the relationship between lower-extremity strength, pelvic floor strength, and UI symptoms at baseline and the 6-week visit.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence, Sarcopenia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This will be determined based on the score on the SPPB.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
71 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Functionally impaired
Arm Type
Active Comparator
Arm Description
Women with urinary incontinence and short physical performance battery score of <9
Arm Title
Functionally normal
Arm Type
Placebo Comparator
Arm Description
Women with urinary incontinence and short physical performance battery score of > 10
Intervention Type
Behavioral
Intervention Name(s)
Pelvic floor muscle exercise
Intervention Description
Standardized pelvic floor muscle exercise regimen
Primary Outcome Measure Information:
Title
Change in number of urinary incontinence episodes
Description
Using a voiding diary
Time Frame
Baseline through Week 6
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Must be born a woman due to the nature of the intervention investigators are studying.
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women, age 70 years or older
Diagnosis of Urinary Incontinence (defined by the QUID assessment as having subscale score for stress ≥4, and/or urge score ≥ 6)
Willing and able to be compliant with pelvic floor muscle exercise intervention (standard of care) for 12 weeks and to log compliance
Willing and able to undergo an extensive physical function evaluation
Exclusion Criteria:
Prior surgical intervention for urinary incontinence within the past 12 months
Hysterectomy within 12 months
Diagnosis of:
Pelvic Organ Prolapse beyond the hymenal ring
Urogenital Fistula
Neurogenic Overactive Bladder (associated with a diagnosis of Multiple -Sclerosis or Stroke within past 12 months)
Incomplete Bladder Emptying/Urinary Retention with PVR >150 ml (measured by bladder scan)
Requires assisted device (4 point cane, walker) for ambulation all /most of the time or wheelchair bound
Having significant cognitive impairment or dementia
Unsafe to exercise (severe cardiopulmonary disease)
Unable/unwilling to provide informed consent
Determined otherwise ineligible by the principal investigator
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Candace Parker-Autry, MD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wake Forest Baptist Health
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35852275
Citation
Parker-Autry C, Neiberg R, Leng XI, Matthews CA, Dumoulin C, Kuchel G, Kritchevsky SB. Examining the Role of Nonsurgical Therapy in the Treatment of Geriatric Urinary Incontinence. Obstet Gynecol. 2022 Aug 1;140(2):243-251. doi: 10.1097/AOG.0000000000004852. Epub 2022 Jul 6.
Results Reference
derived
Learn more about this trial
The Urinary Incontinence Treatment Study
We'll reach out to this number within 24 hrs